bpc-157 działanie BPC 157 Peptyd BPC-157 - co to

2014, pp

Preclinical research Pharmacodynamic research: Evaluating the efficacy of creams in animal models, such as promoting wound healing and anti-inflammatory effects

It was originally developed as an anti-obesity drug candidate because early research suggested it could stimulate lipolysis (fat breakdown) and reduce lipogenesis (fat formation) without the typical growth-promoting or IGF-1raising effects of full HGH

CJC-1295 is an analog of growth hormone-releasing hormone, but its modified with a longer half-life for sustained growth hormone release.2 Meanwhile, ipamorelin mimics ghrelin but operates selectively so that it targets only growth hormone release, having no impact on other hormones (e.g., cortisol) that similar peptides often affect.3 4 Together, they allow your body to produce more growth hormone more often, thus facilitating muscle growth and fat loss over an extended period.5 Because of their complementary time-release characteristics, theyre commonly used together

These changes increase the risk of infertility, subfertility, and chromosomal aberrancies in sperm